Assessment of genetically modified maize MON 95275 (application GMFF-2022-5890).

ABSTRACT: Genetically modified maize MON 95275 was developed to confer protection to certain coleopteran species. These properties were achieved by introducing the mpp75Aa1.1, vpb4Da2 and DvSnf7 expression cassettes. The molecular characterisation data and bioinformatic analyses reveal similarity to known toxins, which was further assessed. None of the identified differences in the agronomic/phenotypic and compositional characteristics tested between maize MON 95275 and its conventional counterpart needs further assessment. The GMO Panel does not identify safety concerns regarding the toxicity and allergenicity of the Mpp75Aa1.1 and Vpb4Da2 proteins and the DvSnf7 dsRNA and derived siRNAs as expressed in maize MON 95275 and finds no evidence that the genetic modification would c

SUBMITTER: EFSA Panel on Genetically Modified Organisms (GMO) 

PROVIDER: S-EPMC11292213 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature